Cargando…
Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria
BACKGROUND: The Plasmodium vivax Duffy Binding Protein (PvDBP) is a key target of naturally acquired immunity. However, region II of PvDBP, which contains the receptor-binding site, is highly polymorphic. The natural acquisition of antibodies to different variants of PvDBP region II (PvDBPII), inclu...
Autores principales: | He, Wen-Qiang, Shakri, Ahmad Rushdi, Bhardwaj, Rukmini, França, Camila T., Stanisic, Danielle I., Healer, Julie, Kiniboro, Benson, Robinson, Leanne J., Guillotte-Blisnick, Micheline, Huon, Christèle, Siba, Peter, Cowman, Alan, King, Christopher L., Tham, Wai-Hong, Chitnis, Chetan E., Mueller, Ivo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400399/ https://www.ncbi.nlm.nih.gov/pubmed/30768655 http://dx.doi.org/10.1371/journal.pntd.0006987 |
Ejemplares similares
-
Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax
por: Gupta, Sonal, et al.
Publicado: (2018) -
Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans
por: Martinez, Francisco J., et al.
Publicado: (2023) -
Plasmodium vivax Invasion of Human Erythrocytes Inhibited by Antibodies Directed against the Duffy Binding Protein
por: Grimberg, Brian T, et al.
Publicado: (2007) -
Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax
por: de Cassan, Simone C., et al.
Publicado: (2015) -
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
por: Hou, Mimi M., et al.
Publicado: (2023)